Estimated read time: 3-4 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] PHA HEA MEQ MTC BIO
[SU]
-- WITH PHOTO -- TO BUSINESS, AND MEDICAL EDITORS:
Specialty Pharmaceutical Distributor BDI Pharma Ramps Up Growth
Initiative With Recent Expansion in Both Current and New Facilities
COLUMBIA, S.C., March 24, 2014 /PRNewswire/ -- BDI Pharma, Inc.
recently completed construction of a new, state-of-the-art
refrigeration unit, tripling the company's cold storage capacity along
with new frozen storage capabilities. Additionally, BDI closed on a
neighboring, 13,000 square foot building providing for the expansion
necessary to accomplish many of the company's key strategic
initiatives. The new facility is located in the same business park as
BDI Pharma's headquarters.
Photo - http://photos.prnewswire.com/prnh/20140324/PH88507-a Photo -
http://photos.prnewswire.com/prnh/20140324/PH88507LOGO-b
"The addition of new cold space was vital for the continued growth of
the company and further indicates a strong commitment from ownership
to continue investing in the rapid growth of BDI Pharma for the coming
years," stated Manuel Martinez, Vice President of Operations for BDI
Pharma. "Along with BDI's sustained growth, recent contract wins
utilizing our alternative distribution program, Linear B Exchange,
have dictated the further expansion of our frozen storage
capabilities."
The newly purchased facility will house current and future employees
assisting with the company's growth in service capabilities. "We were
fortunate to be able to acquire a second building within walking
distance of our headquarters allowing us to grow our business and
expand our corporate campus without any interruption in service,"
stated Richard Gaton, Co-President of BDI Pharma. "We had a banner
year in 2013 with revenue growth of nearly 40% compared to fiscal year
2012. The additional office space will enable BDI to sustain the
continued growth trend as we approach our twentieth anniversary."
About BDI Pharma, Inc.
BDI Pharma has continuously refined the concept of niche distribution,
providing solutions beyond the traditional wholesaler model since
1995. We operate as an extension of our partners' sales force, create
demand, and move market share with each transaction. In this regard,
we maintain a highly selective process when entering into a strategic
partnership. Our approach of serving the manufactures as well as the
customers over nearly two decades has proven successful in varied
market conditions. This is further supplemented through innovative
supply solutions, extensive product knowledge, 24/7 emergency
availability and urgent need delivery. An open-access resource for
reference material, educational literature, market data and online
ordering, BDI Pharma's home web page www.bdipharma.com (also
www.ivig.com) has become an industry-renowned point of reference.
Proprietary programs covering comprehensive reimbursement services -
www.bdiaccess.com and 855-BDI-CARE; and product consignment -
www.bdivantageplus.com; are just a few of the solutions tailored to
the needs of the healthcare community.
BDI Pharma's product portfolio includes IVIG, branded and generic
specialty pharmaceuticals, chemotherapy products, vaccines, albumin,
coagulation factors, high-titer or "hyper" immune globulins, and other
specialty injectables. BDI Pharma is recognized as an "ADR," or
Authorized Distributor of Record, for all of the manufacturers it
represents.
Read more news from BDI Pharma, Inc.
Contact: Brad Davis 800-948-9834 Email
SOURCE BDI Pharma, Inc.
-0- 03/24/2014
/Photo: http://photos.prnewswire.com/prnh/20140324/PH88507-a
http://photos.prnewswire.com/prnh/20140324/PH88507LOGO-b
PRN Photo Desk, photodesk@prnewswire.com
CO: BDI Pharma, Inc.
ST: South Carolina
IN: PHA HEA MEQ MTC BIO
PRN
-- PH88507 --
0000 03/24/2014 12:30:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
